$ESPORTS ENTERTAINMENT GRP(GMBL)$  This to me is bull😛, the profit is way over $352 actually.......

$CN Energy Group Inc.(CNEY)$  Best Material Stocks Gainers Gold Fields (NYSE:GFI) shares increased by 7.7% to $14.2 during Friday's pre-market session. The company's market cap stands at $12.6 billion. Harmony Gold Mining Co (NYSE:HMY) shares rose 6.48% to $4.76. The company's market cap stands at $2.9 billion. McEwen Mining (NYSE:MUX) stock increased by 5.22% to $7.65. The company's market cap stands at $363.1 million. Hecla Mining (NYSE:HL) shares rose 5.19% to $3.85. The company's market cap stands at $2.3 billion. Anglogold Ashanti (NYSE:AU) stock rose 5.18% to $19.69. The company's market cap stands at $8.2 billion. DRDGold (NYSE:DRD) stock rose 5.17% to $8.95. The market value of their outstanding shares is at $770.3 million. Losers Tan

$Kosmos(KOS)$  It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Unfortunately, these high risk investments often have little probability of ever paying off, and many investors pay a price to learn their lesson. Loss making companies can act like a sponge for capital - so investors should be cautious that they're not throwing good money after bad. In contrast to all that, many investors prefer to focus on companies like Kosmos Energy (NYSE:KOS), which has not only revenues, but also profits. Even if this company is fairly valued by the market, investors would agree that generating consistent profits will continue to provide Kosmos Energy

$GeoVax Labs Inc(GOVX)$  As world embraces again for new variants of COVID, Geovax Labs will be at forefront of medical breakthroughs!

$Genprex, Inc.(GNPX)$  Genprex Inc GNPX.OQ reported a quarterly adjusted loss of $1.23​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-5.20. The mean expectation of two analysts for the quarter was for a loss of $1.93 per share. Wall Street expected results to range from $-2.73 to $-1.13 per share. Reported revenue was expected ! Genprex Inc's reported EPS for the quarter was a loss of $1.23​. The company reported a quarterly loss of $4.32 million. Genprex Inc shares had risen by 477.8% this quarter and lost 77.3% so far this year. FORECAST CHANGES The mean earnings estimate of analysts was unchanged in the last three months.​ In the last 30 days, there have been no ea

$NVIDIA Corp(NVDA)$   Nvidia must meet high growth expectations Nvidia is showing signs that it is still in the early phases of meeting demand for data center hardware to support artificial intelligence (AI) workloads. While its second-quarter revenue growth decelerated from the previous quarter, Nvidia still posted a year-over-year increase of 122% in total revenue, which is extraordinary for a leading semiconductor business. Analysts are usually more accurate in modeling a company's near-term financial performance than predicting stock price movements. The consensus analyst estimate has Nvidia's revenue growing 125% this year before increasing 44% next year, according to Yahoo Finance. The high demand for Nvid

$NVIDIA Corp(NVDA)$   Holding until it shoots 2,800%

$Sunshine Biopharma Inc.(SBFM)$  SBFM is skyrocketing up this week because of key healthcare innovation announcements

$Tesla Motors(TSLA)$   Tesla (TSLA, Financial) shares have continued their upward momentum, rising approximately 2.7%, reaching $359.4 in pre-market trading. This comes after a nearly 9% surge on Monday, which propelled Tesla's market capitalization beyond $1.1 trillion. Over the four trading days from last week Wednesday to Monday's close, Tesla's stock climbed a total of 39.22%. Morgan Stanley analysts have noted a significant shift in investor sentiment towards Elon Musk, driving Tesla's stock higher, reaching a two-year high. Investors are also focusing on Tesla's developments beyond automotive sales, including ventures such as the Cybertruck. Looking into the next year, Morgan Stanley anticipates an expansi

$Sunshine Biopharma Inc.(SBFM)$  SBFM News Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has launched nine (9) new generic prescription drugs year-to-date. These launches bring the total number of drugs that the Company has on the market in Canada to sixty-one (61). The Company's marketing and sales efforts are carried out by Nora Pharma Inc. (Nora Pharma), a wholly owned subsidiary of the Company. The new generic prescription drugs launched include Abiraterone, Clobetasol, Daptomycin, Dasatinib, Ertapenem, Hanzema®, Progesterone, Rivaroxaban, and Zoledronic Acid. These n

$Sunshine Biopharma Inc.(SBFM)$  Little, chicken little puck puckek 

$BigBear.ai Holdings(BBAI)$   Follow me every day and you easily get between 10-200% growth in your share portfolio

$Trump Media & Technology(DJT)$   Trump all the way - kaboom $$$$$$$$$

$Wolfspeed Inc.(WOLF)$   Which price target ladies and gents - please inform me - if I sell at that target I'll make another post to give Coins

$Sunshine Biopharma Inc.(SBFM)$  The initial genome expression products following infection by Betacoronavirus, the causative agent of COVID-19, are two large polyproteins, referred to as pp1a and pp1ab. These two polyproteins are cleaved at 15 specific sites by two virus encoded proteases, called Mpro and PLpro, to generate 16 different non-structural proteins essential for viral replication. Mpro and PLpro represent attractive anti-viral drug development targets as they play a central role in the early stages of viral replication. PLpro is of particular interest as a therapeutic target in that, in addition to processing essential viral proteins, it is also responsible for suppression of the human immune system making the virus more life-thr

$Sunshine Biopharma Inc.(SBFM)$  One of the more interesting stocks to watch. In June 2021, we initiated a new research project in which we set out to determine if certain mRNA molecules can be used as anticancer agents. The data collected to date have shown that a selected group of mRNA molecules are capable of destroying cancer cells in vitro including multidrug resistant breast cancer cells (MCF-7/MDR), ovarian adenocarcinoma cells (OVCAR-3), and pancreatic cancer cells (SUIT-2). Studies using non-transformed (normal) human cells (HMEC cells) showed that these mRNA molecules had little cytotoxic effects. These new mRNA molecules, bearing the laboratory name K1.1, are readily adaptable for delivery into patients using the mRNA vaccine techn

$NVIDIA Corp(NVDA)$   $Coinbase Global, Inc.(COIN)$   Yahoo Finance Markets and Data Editor Jared Blikre joins Asking For A Trend to break down today's top market (^DJI, ^IXIC, ^GSPC) movements, including: Markets posting their strongest weekly performance of 2024, Nvidia's (NVDA) addition to the Dow Jones Industrial Average (^DJI), and bitcoin's (BTC-USD) notable outperformance compared to gold (GC=F).

$Wolfspeed Inc.(WOLF)$   After some setback in a few company announcements - this is a no-brainer of a skyrocket up

$NVIDIA Corp(NVDA)$   President Trump will be great for AI - AI Projects and related Data Center uptake will be tremendous

$Trump Media & Technology(DJT)$   Americans awoke Wednesday to the news that Donald J. Trump had once again won the White House, a remarkable political comeback that buoyed investors and drew congratulations from around the globe. His victory was confirmed just after 5:30 a.m. Eastern when he captured the battleground state of Wisconsin, putting him above the threshold of 270 electoral votes. Mr. Trump’s supporters were celebrating a clear-cut win in what pre-election polls had suggested would be a tight race. It will take days for a final vote count, but Mr. Trump appeared on track to win not only the Electoral College but also the national popular vote. It was the best showing for a Republican presidential